Search images on Google      Product Monograph

Active Ingredients:

• durvalumab, 50 MG/ML

DIN: 02468816

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription

Company: ASTRAZENECA CANADA INC  –  official site

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FF - (ATC, WHO)
• L01FF03 - DURVALUMAB (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 2.4ML/10ML

 

External Links for Imfinzi:

Search on Google

• Imfinzi side effects
• Imfinzi dosage
• durvalumab side effects
• durvalumab dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find imfinzi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.